In general obesity, pioglitazone improved IR and caused a lowered waist-to-hip ratio via increasing lower body AT without changing VAT in general obesity [47]
Any potential anti-inflammatory benefits would be considered secondary to their primary metabolic effects
Currently looking into private treatment
This evidence supports that combined use is generally well-tolerated in most patients
Tianhui Wang, [email protected] This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
A registered dietitian builds the nutrition side that a prescription alone does not: protecting lean mass, closing nutrient gaps as appetite drops, managing nausea and other GI side effects with food strategy, and planning for how you eat once the medication is tapered or stopped
